Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001659323-17-000001
Filing Date
2017-06-01
Accepted
2017-06-01 11:45:56
Documents
1
Effectiveness Date
2017-06-01
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 14551
  Complete submission text file 0001659323-17-000001.txt   15559
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 1 (872) 225-6077
Iterum Therapeutics Ltd (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-287819 | Film No.: 17883856